<?xml version="1.0" encoding="utf-8"?>
<File id="78">
  <Title><![CDATA[<p>Will RTS,S be made available as part of a tiered pricing structure?</p>]]></Title>
  <HtmlTextKey><![CDATA[]]></HtmlTextKey>
  <HtmlText><![CDATA[<p>RTS,S is currently being developed solely for use in sub-Saharan Africa since burden of malaria caused by <em>P. falciparum</em> is mostly occurring in sub-Saharan African children under 5 years of age. Tiered pricing (where prices are aligned to a country&rsquo;s ability to pay) is not applicable because this vaccine will not be made available in higher income countries.</p>]]></HtmlText>
  <Topic>PRICING AND FINANCING</Topic>
  <SubTopic>GENERAL</SubTopic>
  <References><![CDATA[]]></References>
  <pdf>xml/content/78/78.pdf</pdf>
  <docx>xml/content/78/78.docx</docx>
  <contentLastUpdated>2015-12-15</contentLastUpdated>
  <RelatedFiles />
</File>